| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-08 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-06 |